Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Fluoroantimonic acid" patented technology

Fluoroantimonic acid is an inorganic compound with the chemical formula H₂FSbF₆ (also written H₂F[SbF₆], 2HF·SbF₅, or simply HF-SbF₅). It is an extremely strong acid, easily qualifying as a superacid. The Hammett acidity function, H₀, has been measured for different ratios of HF:SbF₅. While the H₀ of pure HF is −15, addition of just 1 mol % of SbF₅ lowers it to around −20. However, further addition of SbF₅ results in rapidly diminishing returns, with the H₀ reaching −21 at 10 mol %. The use of an extremely weak base as indicator shows that the lowest attainable H₀, even with > 50 mol % SbF₅, is somewhere between −21 and −23.

Single-component stable luminescent device embedding composition at room temperature

The invention discloses a single-component encapsulating adhesive of a luminescent device with constant room temperature, and the components are: (1) epoxide resin and / or a monomer containing polymerizable double bond of C=C; (2) cation solicitation; (3) accessory ingredient: one or a combination of more than one of silicone adhesive accessory ingredient, foam killer, release agent, toner, antioxidant, and light scattering agent; the cation solicitation is: one of or a combination of more than one of triarylated matte onium based six fluorine antimonite, triarylated matte onium based six fluorine phosphate, phenyl octyloxy iodobenzene onium based six fluorine antimonite, quaternary ammonium group six fluorine antimonite, and quaternary ammonium group triflate. The encapsulating adhesive of the luminescent device is easy to be preserved; the use is convenient; double constituents of encapsulating adhesive are not needed to be blended when the encapsulation is conducted; the polymerization temperature is relatively low; the curing time is short, and the cured colloid is colorless and transparent with high transmittancy; the agglutinated property is constant; the adhesive is applicable to the encapsulating of the luminescent device, particularly for the encapsulating of a luminous diode.
Owner:杨钢

Radiation sensitive material and method for forming pattern

A copolymer expressed by the following structural formulawas obtained by loading adamantyl methacrylate monomer and t-butyl acrylate monomer by 1:1, then conducting polymerization, adding AIBN as a polymerization initiator, and then conducting precipitation purification with methanol. Then to the copolymer, triphenylsulfonium hexafluoroantimonate was added to prepare a cyclohexanone solution. This solution was applied to a wafer, and exposed to a KrF excimer stepper and developed. The threshold energy Eth was 50 mJ / cm2. A 0.45 μm-wide L & S was formed at 130 mJ / cm2. The radiation sensitive material has good transparency and etching resistance, high sensitivity, and little peeling.
Owner:FUJITSU SEMICON LTD

2-(2,6-dicyanophenyl) imidazo [1,2-alpha] pyridine compound and preparation method thereof

ActiveCN106831765AAntiviral Biological ActivityAnti-apoptotic biological activityOrganic chemistrySodium bicarbonateDichloroethane
The invention discloses a 2-(2,6-dicyanophenyl) imidazo [1,2-alpha] pyridine compound obtained through a direct nitrile grouping reaction method of a 2-phenyl-imidazo [1,2-alpha] pyridine compound and N-cyan-N-phenyl p-methylphenyl sulphonylamine (NCTS). The reaction is characterized by utilizing dichloro (pentamethyl cyclopentadienyl) rhodium (III) dimer ([RhCp*Cl2]2) and silver hexafluoroantimonate (AgSbF6) as catalysts, adopting sodium bicarbonate (NaHCO3) as an additive, adopting 1,2-dichloroethane as a reaction solvent, and realizing nitrile grouping reaction of the 2-phenyl-imidazo [1,2-alpha] pyridine compound and the N-cyan-N-phenyl p-methylphenyl sulphonylamine (NCTS). The method is simple and efficient, a functionalization reaction type of the 2-phenyl-imidazo [1,2-alpha] pyridine compound is enriched, and meanwhile, a new reaction mode of the N-cyan-N-phenyl p-methylphenyl sulphonylamine (NCTS) is also realized. The method has significance on research and application of nitrile grouping reaction of the 2-phenyl-imidazo [1,2-alpha] pyridine compound.
Owner:ZHENGZHOU UNIV

Axially chiral biaryl compound with P-stereo center and synthesis method and application thereof

The invention discloses an axially chiral biaryl compound with a P-stereo center and a synthesis method and application thereof. The structural formula of the compound is shown in the specification, chiral trivalent rhodium [CpXRh(III)] is used as a catalyst, diaryl phosphonamide and diaryl acetylene are used as raw materials, and enantioselective coupling is conducted under the assistance of silver trifluoromethanesulfonate or silver hexafluoroantimonate and silver acetate to obtain the compound. Diarylacetylene is taken as an initial raw material, the compound is stable in property and easy to prepare, but the compound is seldom applied to arylation reaction. In the prior art, aryl arylation is mainly carried out by using brominated aromatic hydrocarbon, arylboronic acid and the like. The simple diarylacetylene is adopted as an arylation reagent, the axially chiral biaryl and the P-center chiral compound are stereoscopically and specifically synthesized through double activation of C-H bonds in the aryl phosphonamide and the diarylacetylene, and the method has the advantages of being mild in reaction condition, high in enantioselectivity, good in diastereoselectivity and the like.
Owner:SHAANXI NORMAL UNIV

Platinum(II) ammine selenourea complexes and methods of treating cancer

A platinum(II) complex of formula (I),or a pharmaceutically acceptable solvate or tautomer thereof, wherein R1 and R2 are each independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted arylalkyl, or an optionally substituted aryl; or wherein R1 and R2 together form a five-, six-, or seven-membered ring with the nitrogen atoms to which they are attached; and X is a nitrate anion, a hexafluorophosphate anion, a hexafluoroantimonate anion, a trifluoromethanesulfonate anion, a tetrafluoroborate anion, a perchlorate anion, or a halide anion. A pharmaceutical composition containing the platinum(II) complex of formula (I), and a method of treating cancer are also disclosed.
Owner:KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS +1

Production process of curing agent for yarn impregnation

The invention relates to a production process of a curing agent for yarn impregnation. The production process is characterized by specifically comprising the following steps: S1, preparing sodium pyroantimonate; S2, preparing hexafluoroantimonic acid; S3, preparing a silver hexafluoroantimonate mother solution; S4, concentrating, cooling and crystallizing the silver hexafluoroantimonate mother liquor; and S5, recrystallizing and purifying the crude silver hexafluoroantimonate crystal. Antimonous oxide is mixed with an acetic acid solution containing hydrogen fluoride, and compared with a method of mixing antimonous oxide with a hydrofluoric acid aqueous solution or anhydrous hydrofluoric acid, the process has the advantages of mild reaction conditions, simple and easily available raw materials, low equipment requirements, high hexafluoroantimonic acid generation rate, fewer impurities and higher silver hexafluoroantimonate product yield. Hexafluoroantimonic acid reacts with silver carbonate to generate the silver hexafluoroantimonate mother solution, and then silver hexafluoroantimonate is prepared from sodium pyroantimonate and silver carbonate in a hydrogen fluoride aqueous solution in one step. The method has the advantages of mild reaction conditions, low raw material price, small environmental pollution and high impurity removal rate, and the purity of the finally obtainedproduct is high and reaches 99% or above.
Owner:如皋市丹凤纺织有限公司

Production process of cationic curing agent

The invention relates to a production process of a cationic curing agent. The production process is characterized by specifically comprising the following steps: S1, preparing sodium pyroantimonate; S2, preparing hexafluoroantimonic acid; S3, preparing a silver hexafluoroantimonate mother solution; S4, concentrating, cooling and crystallizing the silver hexafluoroantimonate mother solution; and S5, recrystallizing and purifying coarse silver hexafluoroantimonate crystals. According to the present invention, the mixing of the antimony trioxide and a hydrogen fluoride-containing acetic acid solution has advantages of mild reaction condition, simple and easily available raw materials, low equipment requirement, high generation rate of hexafluoroantimonic acid, less impurity content, and high yield of the silver hexafluoroantimonate product compared with the mixing of antimony trioxide and a hydrofluoric acid aqueous solution or anhydrous hydrofluoric acid. Hexafluoroantimonic acid reacts with silver carbonate to generate a silver hexafluoroantimonate mother solution; and then silver hexafluoroantimonate is prepared from sodium pyroantimonate and silver carbonate in a hydrogen fluoride aqueous solution in one step. The method is mild in reaction condition, low in raw material price, small in environmental pollution and high in impurity removal rate, and the purity of the finally obtained product is high and reaches 99% or above.
Owner:NANTONG SYNASIA NEW MATERIAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products